4//SEC Filing
Tenjarla Srini 4
Accession 0001493152-24-028205
CIK 0001708599other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 5:10 PM ET
Size
5.6 KB
Accession
0001493152-24-028205
Insider Transaction Report
Form 4
Tenjarla Srini
SVP, CMC & Formulation
Transactions
- Award
Stock Option (right to buy)
2024-07-15+185,000→ 185,000 totalExercise: $9.50Exp: 2034-07-15→ Common Stock (185,000 underlying)
Footnotes (1)
- [F1]The stock options vest as to 61,666 of the underlying shares on July 15, 2025, and thereafter in substantially equal installments such that the stock options shall be fully vested on the third anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
Documents
Issuer
Serina Therapeutics, Inc.
CIK 0001708599
Entity typeother
Related Parties
1- filerCIK 0002029985
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 5:10 PM ET
- Size
- 5.6 KB